Diabeticfoot(DF)isoneofthemostcommonchroniccomplicationsofdiabetesanditssecondaryinfectionisthemajorcauseofnon-traumaticamputation,whichgreatlyaffectsthequalityoflifeofdiabeticpatientsandbringsseriouseconomicburdenstofamiliesandthesociety.Mesenchymalstemcell(MSCs)treatmentcaneffectivelypromoteangiogenesisandwoundhealingandisthusanewmethodforthetreatmentofDF.ThisarticlereviewstheresearchadvancesinMSCsinthetreatmentofDF,inordertoprovideatheoreticalbasisfortheclinicaltreatmentofDF.
LiuQun, WangZhiwen, LüXiaorui, ZhuLingyan. Researchadvancesinmesenchymalstemcellsintreatmentofdiabeticfoot[J]. Journal of Chongqing Medical University,2020,45(3):306-